Company Update2 Min Read InvestyWise NewsonJanuary 30, 2026 Aegis Logistics Strong Performance in Q3 FY2026 and 9M FY2026 Aegis Logistics reported a robust performance for Q3 FY2026 and 9M FY2026. In 9M FY26, the company recorded its highest-ever revenues in the…
Company Update1 Min Read InvestyWise NewsonJanuary 30, 2026 Arvind Limited Q3 FY26 Results – Robust Growth in Textiles and AMD Arvind Limited reported strong Q3 FY26 results, driven by robust growth in its AMD and garmenting segments. Revenue increased by 14% YoY, and…
Company Update2 Min Read InvestyWise NewsonJanuary 30, 2026 Arvind Q3 FY26 Revenue Up 14%, EBITDA Climbs 15% Arvind Ltd. reported a 14% increase in revenue, reaching ₹2,373 Cr, for Q3 FY26. EBITDA grew by 15% to ₹286 Cr, with margins exceeding 12%.…
Company Update2 Min Read InvestyWise NewsonJanuary 30, 2026 RattanIndia Power Limited Q3 FY26 Earnings Update RattanIndia Power Limited announced its Q3 FY26 earnings, showing improved operational performance and key financial achievements. The company…
Company Update2 Min Read InvestyWise NewsonJanuary 30, 2026 Tega Industries Deregistration of Australian Subsidiary Approved Tega Industries’ Board of Directors has approved the voluntary deregistration of its wholly-owned subsidiary, Tega Industries Australia…
Company Update2 Min Read InvestyWise NewsonJanuary 30, 2026 Strides Pharma Q3FY26 EBITDA Reaches ₹2,359m, Up 12.2% YoY Strides Pharma Science reported a strong Q3FY26 with record quarterly EBITDA of ₹2,359m, a 12.2% year-over-year increase. Operational PAT grew…
Company Update1 Min Read InvestyWise NewsonJanuary 30, 2026 IKS Health Grants 122,000 Employee Stock Options Under ESOP Plan IKS Health has granted 122,000 employee stock options to eligible employees under its Employee Stock Option Plan 2022 (IKS ESOP Plan). The…
Company Update1 Min Read InvestyWise NewsonJanuary 30, 2026 Strides Pharma Science Highest Ever Quarterly EBITDA of ₹2,359m in Q3FY26 Strides Pharma Science reported its highest ever quarterly EBITDA of ₹2,359m in Q3FY26. Revenue grew by 3.6% YoY to ₹11,946m. EBITDA margin…
Company Update1 Min Read InvestyWise NewsonJanuary 30, 2026 Natco Pharma Acquires Remaining Stake in PT NATCO Lotus Farma Natco Pharma has acquired the remaining 49% stake in PT NATCO Lotus Farma from PT Lotus Farma Indonesia. This acquisition gives Natco Pharma,…
Company Update1 Min Read InvestyWise NewsonJanuary 30, 2026 Balaji Amines Revenue at ₹336 Crore, EBITDA at ₹62 Crore for Q3FY26 Balaji Amines reported revenue of ₹336 Crore and EBITDA of ₹62 Crore for Q3FY26. Net profit stood at ₹31 Crore. The company highlighted stable…